-
We Are Transforming Innovative
Therapies through Human
Genetics InsightsData to Medicine (D2M) is transforming innovative drug discovery and development, harnessing the power of human genetic data. Through our INGENUITI platform, we are able to systematically identify disease causal genes in scale, and leverage human genetic insights to advance drugs with the potential for substantially improved clinical success. Our initial focus is on oncology and immune-inflammatory diseases with limited therapeutic options.
-
We Are Mining Disease
Causal Genes From Vast
Amounts of Genomic DataData to Medicine (D2M) is transforming innovative drug discovery and development, harnessing the power of human genetic data. Through our INGENUITI platform, we are able to systematically identify disease causal genes in scale, and leverage human genetic insights to advance drugs with the potential for substantially improved clinical success. Our initial focus is on oncology and immune-inflammatory diseases with limited therapeutic options.
-
We Are Combating Cancer &
Inflammatory Diseases Using
Human Genetics-Validated TargetsData to Medicine (D2M) is transforming innovative drug discovery and development, harnessing the power of human genetic data. Through our INGENUITI platform, we are able to systematically identify disease causal genes in scale, and leverage human genetic insights to advance drugs with the potential for substantially improved clinical success. Our initial focus is on oncology and immune-inflammatory diseases with limited therapeutic options.
What We Stand For
Vision
Treating Disease Through Human Genetics Data-Driven Innovation
Mission
To Create Transformative Medicine by Unlocking the Potential of Human Genetics
Focus
Broadened Therapy for Cancer, and Immune-Inflammatory Diseases
Harnessing Human Genetics
How We Do It
Our INGENUITI platform systematically identifies disease targets of significant value and confidence, leveraging insights from human genetics.
Our Team
Our team of seasoned geneticists and drug developers has built a pipeline of therapeutics for cancer and immune-inflammatory diseases. Our goal is to substantially improve clinical success, ultimately delivering revolutionary medicines to patients in need.